Identifying neuromodulation targets for pain in the human brain
识别人脑疼痛的神经调节目标
基本信息
- 批准号:10589120
- 负责人:
- 金额:$ 22.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-15 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:Adverse effectsAnalgesicsAtlasesBrainBrain MappingBrain hemorrhageBrain regionClinical TrialsCompensationDataData SetDatabasesDedicationsDependenceDevelopmentDystoniaEnrollmentFutureHumanIschemic StrokeLesionLinkLocationMagnetic Resonance ImagingMapsMental DepressionMental disordersMetabolismMethodsMotor CortexNeuroanatomyNeurologicNeurologic SymptomsPainPain MapPain managementParkinson DiseasePatientsQuality of lifeQuestionnairesReportingRestSymptomsTestingThalamic structureTranscranial magnetic stimulationTremoraddictionbrain basedcentral painclinically significantcohortfluorodeoxyglucose positron emission tomographyimprovedmetabolic imagingnervous system disorderneuroimagingneuropsychiatric symptomneuroregulationnovel strategiespain reliefpainful neuropathypharmacologicpost strokepost stroke painprospectivepsychiatric symptomside effectstroke outcometext searchingthalamic paintherapeutic target
项目摘要
Identifying neuromodulation targets for pain in the human brain
Neuropathic pain is prevalent across many different neurological and psychiatric disorders and has one of the
largest adverse effects on quality of life. Pharmacological pain treatments often have limited efficacy and
undesirable side effects, including dependence and addiction. Neuromodulation treatments such as transcranial
magnetic stimulation show promise for pain while avoiding the side effects associated with pain medications. An
obstacle to improving neuromodulation treatment is identifying the human brain regions responsible for pain.
Traditional functional neuroimaging studies only identify correlates of pain which could be causing symptoms,
compensating for symptoms, or simply serving as a marker of symptoms. This ambiguity is a problem when
seeking to identify therapeutic targets. Unlike functional neuroimaging, lesion studies allow for casual links
between symptoms and human neuroanatomy. The PI has developed and validated a new method to identify
neuromodulation targets in the human brain based on brain lesions and a map of human brain connectivity.
Called lesion network mapping, this approach has been used to map numerous neurological and psychiatric
symptoms to brain networks (Fox 2018, NEJM). Brain networks identified using this approach have proven to
be effective neuromodulation targets for symptoms such as tremor, Parkinson’s disease, dystonia, and
depression. Our preliminary data suggests this method is equally valuable for mapping pain, including
identification of therapeutic targets. Here, we will use this approach to map pain to a human brain circuit based
on lesion locations previously reported to cause pain (Aim 1), a dedicated dataset focused on thalamic lesions
causing or not causing pain (Aim 2), and a prospective dataset of patients longitudinally assessed for
development of post-stroke pain (Aim 3). We hypothesize that; (1) lesions causing pain will map to a common
brain network; (2) this network will show abnormal metabolism in patients with post stroke pain, (3) this network
will predict who will develop post-stroke pain; and (4) this pain network will include primary motor cortex, our
best validated neuromodulation target for pain. Completion of these aims will identify a candidate human brain
network causally linked to pain. Once identified, this network can be validated in future trials with more detailed
characterization of post stroke pain and used as an improved target for neuromodulation that can be tested in
clinical trials.
识别人脑中疼痛的神经调节靶点
神经性疼痛在许多不同的神经和精神疾病中普遍存在,并且具有其中一种
对生活质量的最大负面影响。药物疼痛治疗通常具有有限的功效,
不良副作用,包括依赖和成瘾。神经调节治疗,如经颅
磁刺激显示出对疼痛的承诺,同时避免了与止痛药相关的副作用。一个
改善神经调节治疗的障碍是识别负责疼痛的人脑区域。
传统的功能性神经影像学研究只能识别可能导致症状的疼痛相关性,
补偿症状,或者仅仅作为症状的标记。这种模糊性是一个问题,
寻找治疗靶点与功能性神经影像学不同,病变研究允许偶然的联系
症状和人类神经解剖学之间的联系PI开发并验证了一种新的方法来识别
基于脑损伤和人脑连接图,神经调节靶点在人脑中。
称为病变网络映射,这种方法已被用于映射许多神经和精神疾病
症状到大脑网络(Fox 2018,NEJM)。使用这种方法识别的大脑网络已被证明
是诸如震颤、帕金森病、肌张力障碍等症状的有效神经调节靶标,
萧条我们的初步数据表明,这种方法对于映射疼痛同样有价值,包括
确定治疗靶点。在这里,我们将使用这种方法来映射疼痛到人类大脑回路,
关于先前报告的导致疼痛的病变位置(目标1),一个专注于丘脑病变的专用数据集
引起或不引起疼痛(目标2),以及纵向评估的患者前瞻性数据集,
中风后疼痛的发展(目标3)。我们假设:(1)引起疼痛的病变将映射到一个共同的
脑网络;(2)该网络将显示中风后疼痛患者的代谢异常,(3)该网络
将预测谁会患上中风后疼痛;(4)这个疼痛网络将包括初级运动皮层,我们的
最有效的疼痛神经调节靶点。完成这些目标将确定一个候选人的大脑
与疼痛有因果关系的网络。一旦确定,该网络可以在未来的试验中进行验证,
中风后疼痛的表征,并用作神经调节的改进目标,可以在
临床试验
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL D FOX其他文献
MICHAEL D FOX的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL D FOX', 18)}}的其他基金
Using Brain Lesions and Deep Brain Stimulation to Identify an Epilepsy Circuit
利用脑损伤和深部脑刺激来识别癫痫回路
- 批准号:
10634692 - 财政年份:2022
- 资助金额:
$ 22.38万 - 项目类别:
Using brain lesions and deep brain stimulation to identify an epilepsy circuit
利用脑损伤和深部脑刺激来识别癫痫回路
- 批准号:
10501784 - 财政年份:2022
- 资助金额:
$ 22.38万 - 项目类别:
Identifying neuromodulation targets for pain in the human brain
识别人脑疼痛的神经调节目标
- 批准号:
10450987 - 财政年份:2022
- 资助金额:
$ 22.38万 - 项目类别:
Targeted modulation of symptom-specific brain circuits with transcranial magnetic stimulation
通过颅磁刺激有针对性地调节症状特异性脑回路
- 批准号:
10369674 - 财政年份:2021
- 资助金额:
$ 22.38万 - 项目类别:
Transdiagnostic memory, mood and motor circuits in Alzheimer's and neurodegenerative disease
阿尔茨海默病和神经退行性疾病的跨诊断记忆、情绪和运动回路
- 批准号:
10358675 - 财政年份:2021
- 资助金额:
$ 22.38万 - 项目类别:
Targeted modulation of symptom-specific brain circuits with transcranial magnetic stimulation
通过颅磁刺激有针对性地调节症状特异性脑回路
- 批准号:
10195920 - 财政年份:2021
- 资助金额:
$ 22.38万 - 项目类别:
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptoms
利用人脑连接来识别抑郁症状的因果神经解剖学基础
- 批准号:
10646488 - 财政年份:2017
- 资助金额:
$ 22.38万 - 项目类别:
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptoms
利用人脑连接来识别抑郁症状的因果神经解剖学基础
- 批准号:
10242694 - 财政年份:2017
- 资助金额:
$ 22.38万 - 项目类别:
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptoms
利用人脑连接来识别抑郁症状的因果神经解剖学基础
- 批准号:
9766881 - 财政年份:2017
- 资助金额:
$ 22.38万 - 项目类别:
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptoms
利用人脑连接来识别抑郁症状的因果神经解剖学基础
- 批准号:
10290232 - 财政年份:2017
- 资助金额:
$ 22.38万 - 项目类别:
相似海外基金
Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
- 批准号:
10641500 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
- 批准号:
10485593 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
- 批准号:
10728526 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别:
Development of LPA5 Antagonists as Analgesics
LPA5 拮抗剂镇痛药的开发
- 批准号:
10638278 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
- 批准号:
10621646 - 财政年份:2023
- 资助金额:
$ 22.38万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10425794 - 财政年份:2022
- 资助金额:
$ 22.38万 - 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
- 批准号:
22K19602 - 财政年份:2022
- 资助金额:
$ 22.38万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
- 批准号:
10512672 - 财政年份:2022
- 资助金额:
$ 22.38万 - 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
- 批准号:
10821681 - 财政年份:2022
- 资助金额:
$ 22.38万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10721752 - 财政年份:2022
- 资助金额:
$ 22.38万 - 项目类别: